Pivotal bioVenture Partners Fund I L.P. 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 9:41 pm Unchanged |
2024-02-12 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.100% |
0 (Unchanged) |
Filing |
| 2021-08-13 5:02 pm Purchase |
2021-02-21 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.400% |
1,166,952 (+61.70%) |
Filing |
| 2021-02-17 4:56 pm Purchase |
2021-02-09 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Pivotal bioVenture Partners Fund I L.P. | 1,891,467 5.500% |
1,891,467 (New Position) |
Filing |